Across TCGA pan-cancer cohorts, IGLV4-60 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of IGLV4-60’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where IGLV4-60 RNA is repressed in tumor relative to normal tissue. In most cancer types IGLV4-60 is over-expressed in tumor, although a few such as COAD and READ show the opposite, repressed pattern.
COAD, READ, and KIRC are the cancer types where IGLV4-60 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in IGLV4-60 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.